EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness

Qing Niu, Haixiao Zhang, Fang Wang, Xing Xu, Yuechen Luo, Baolin He, Mingxia Shi, Erlie Jiang, Xiaoming Feng

Molecular Therapy · 2024-06 · 32 (6) · 1875-1894

DOI: 10.1016/j.ymthe.2024.03.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024-06. Verfasst von Qing Niu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Mitochondria, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Municipal Natural Science Foundation, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor-T (CAR-T) cell has been developed as a promising agent for patients with refractory or relapsed lymphoma and leukemia, but not all the recipients could achieve a long-lasting remission. The limited capacity of in vivo expansion and memory differentiation post activation is one of the major reasons for suboptimal CAR-T therapeutic efficiency. Nitric oxide (NO) plays multifaceted roles in mitochondrial dynamics and T cell activation, but its function on CAR-T cell persistence and anti-tumor efficacy remains unknown. Herein, we found the continuous signaling from CAR not only promotes excessive NO production, but also suppressed S-nitrosoglutathione reductase (GSNOR) expression in T cells, which collectively led to increased protein S-nitrosylation, resulting in impaired mitochondrial fitness and deficiency of T cell stemness. Intriguingly, enforced expression of GSNOR promoted memory differentiation of CAR-T cell after immune activation, rendered CAR-T better resistance to mitochondrial dysfunction, further enhanced CAR-T cell expansion and anti-tumor capacity in vitro and in a mouse tumor model. Thus, we revealed a critical role of NO in restricting CAR-T cell persistence and functionality, and defined that GSNOR overexpression may provide a solution to combat NO stress and render patients with more durable protection from CAR-T therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaReceptors, Chimeric AntigenImmunotherapy, AdoptiveAnimalsMiceHumansAldehyde OxidoreductasesT-LymphocytesNitric OxideCell Line, TumorXenograft Model Antitumor AssaysLymphocyte ActivationSignal Transduction

Stichwörter der Autor:innen

CAR-TGSNORT cell stemnessmitochondrial fitnessnitric oxide

Substanzen

Receptors, Chimeric AntigenAldehyde OxidoreductasesNitric Oxideformaldehyde dehydrogenase, glutathione-independent

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
  • Department of Hematology, Hematology Research Center of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.

Förderung

  • National Natural Science Foundation of China
  • Tianjin Municipal Natural Science Foundation
  • CAMS Innovation Fund for Medical Sciences
  • Tianjin Municipal Education Commission
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Chinese Academy of Meteorological Sciences
  • National Key Research and Development Program of China
  • Tianjin Municipal Science and Technology Committee

Zitieren

APA

Niu, Q., Zhang, H., Wang, F., Xu, X., Luo, Y., He, B., Shi, M., Jiang, E., & Feng, X. (2024). GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness. Molecular Therapy, 32(6), 1875-1894. https://doi.org/10.1016/j.ymthe.2024.03.033

Vancouver

Niu Q, Zhang H, Wang F, Xu X, Luo Y, He B, et al. GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness. Molecular Therapy. 2024;32(6):1875-1894. doi:10.1016/j.ymthe.2024.03.033

BibTeX
@article{Niu2024,
  author = {Niu, Qing and Zhang, Haixiao and Wang, Fang and Xu, Xing and Luo, Yuechen and He, Baolin and Shi, Mingxia and Jiang, Erlie and Feng, Xiaoming},
  title = {GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness},
  journal = {Molecular Therapy},
  year = {2024},
  volume = {32},
  number = {6},
  pages = {1875--1894},
  doi = {10.1016/j.ymthe.2024.03.033}
}
Kostenlos starten →